Income Statement Alaunos Therapeutics, Inc.

Stocks

TCRT

US98973P3091

Biotechnology & Medical Research

Market Closed - Nasdaq 15:51:24 2026-08-14 EDT			5-day change	1st Jan Change
1.950 ^USD	-2.01%		-2.01%	-39.63%

06-29	Alaunos Therapeutics Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment For Body Fat Percentage In 48-Day DIO Mouse Study	CI
05-26	Alaunos Therapeutics Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies	CI

90ae6604fa0c80784db.smqultFzQWFfZWvwfKG6Oo9tOxsH5k1RVOuYPTH1mkc.1ibFpag6BhkFHCGZBfLsd70Zf0R3jCxlMajKf3-F1BPrA-_-mUQoLwcgUw

Published financial data: ALAUNOS THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	398K	2.92M	5K	10K	5K
Total Revenues	398K	2.92M	5K	10K	5K
Cost of Goods Sold, Total	49.64M	22.52M	16.28M	362K	1.36M
Gross Profit	-49.24M	-19.6M	-16.27M	-352K	-1.36M
Selling General & Admin Expenses, Total	27.56M	13.14M	12.22M	4.46M	2.87M
Other Operating Expenses, Total	27.56M	13.14M	12.22M	4.46M	2.87M
Operating Income	-76.81M	-32.74M	-28.49M	-4.81M	-4.22M
Interest Expense, Total	-	-3.15M	-1.92M	-	-
Net Interest Expenses	-	-3.15M	-1.92M	-	-
Other Non Operating Income (Expenses)	-1.2M	529K	1.05M	133K	49K
EBT, Excl. Unusual Items	-78.01M	-35.36M	-29.37M	-4.68M	-4.18M
Restructuring Charges	-	-	-1.27M	-	-
Asset Writedown	-740K	-	-4.8M	-	-
Other Unusual Items	-	-2.37M	298K	-	-
EBT, Incl. Unusual Items	-78.75M	-37.73M	-35.14M	-4.68M	-4.18M
Earnings From Continuing Operations	-78.75M	-37.73M	-35.14M	-4.68M	-4.18M
Net Income to Company	-78.75M	-37.73M	-35.14M	-4.68M	-4.18M
Net Income - (IS)	-78.75M	-37.73M	-35.14M	-4.68M	-4.18M
Preferred Dividend and Other Adjustments	-	-	-	-	106K
Net Income to Common Incl Extra Items	-78.75M	-37.73M	-35.14M	-4.68M	-4.28M
Net Income to Common Excl. Extra Items	-78.75M	-37.73M	-35.14M	-4.68M	-4.28M
Per Share Items
Net EPS - Basic	-55.1	-26.06	-21.97	-2.92	-2.2
Basic EPS - Continuing Operations	-55.1	-26.06	-21.97	-2.92	-2.2
Basic Weighted Average Shares Outstanding	1.43M	1.45M	1.6M	1.6M	1.95M
Net EPS - Diluted	-55.1	-26.06	-22	-2.92	-2.2
Diluted EPS - Continuing Operations	-55.1	-26.06	-22	-2.92	-2.2
Diluted Weighted Average Shares Outstanding	1.43M	1.45M	1.6M	1.6M	1.95M
Normalized Basic EPS	-34.11	-15.27	-11.47	-1.83	-1.34
Normalized Diluted EPS	-34.11	-15.27	-11.47	-1.83	-1.34
Supplemental Items
EBITDA	-74.21M	-29.98M	-26.18M	-4.81M	-4.22M
EBITA	-76.81M	-32.74M	-28.49M	-4.81M	-4.22M
EBIT	-76.81M	-32.74M	-28.49M	-4.81M	-4.22M
EBITDAR	-72.82M	-29.22M	-25.75M	-	-
Normalized Net Income	-48.76M	-22.1M	-18.35M	-2.92M	-2.61M
Interest on Long-Term Debt	-	3.15M	1.92M	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	27.56M	13.14M	12.22M	4.46M	2.87M
Research And Development Expense From Footnotes	49.64M	25.02M	16.28M	362K	1.36M
Net Rental Expense, Total	1.39M	756K	428K	-	-
Imputed Operating Lease Interest Expense	-	781K	-	-	-
Imputed Operating Lease Depreciation	-	-24.56K	-	-	-
Stock-Based Comp., COGS (Total)	2.6M	868K	439K	17K	210K
Stock-Based Comp., G&A Exp. (Total)	8.18M	2.66M	2.36M	418K	586K
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	10.77M	3.53M	2.8M	435K	796K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	76.05M	39.06M	6.06M	1.09M	1.38M
Total Cash And Short Term Investments	76.05M	39.06M	6.06M	1.09M	1.38M
Accounts Receivable, Total	-	4K	1K	5K	3K
Other Receivables	1.11M	-	-	-	-
Total Receivables	1.11M	4K	1K	5K	3K
Prepaid Expenses	1.67M	799K	2.2M	1.66M	378K
Restricted Cash	-	13.94M	-	-	-
Other Current Assets, Total	-	-	-	-	222K
Total Current Assets	78.83M	53.8M	8.26M	2.76M	1.99M
Gross Property Plant And Equipment	22.77M	20.4M	15K	15K	98K
Accumulated Depreciation	-7.41M	-9.81M	-13K	-15K	-7K
Net Property Plant And Equipment	15.36M	10.6M	2K	0	91K
Deferred Charges Long-Term	-	-	-	-	887K
Other Long-Term Assets, Total	673K	542K	-	-	-
Total Assets	94.86M	64.94M	8.26M	2.76M	2.97M
Liabilities
Accounts Payable, Total	1.37M	1.39M	616K	516K	613K
Accrued Expenses, Total	6.08M	5.45M	1.34M	176K	200K
Current Portion of Long-Term Debt	7.87M	16.76M	-	-	-
Current Portion of Leases	729K	558K	-	-	-
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	-	-	-	-	-
Total Current Liabilities	16.04M	24.17M	1.96M	692K	813K
Long-Term Debt	16.25M	-	-	-	-
Long-Term Leases	4.52M	2.19M	-	-	-
Unearned Revenue Non Current	-	-	-	-	-
Other Non Current Liabilities	-1K	28K	-	-	-
Total Liabilities	36.81M	26.38M	1.96M	692K	813K
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	216K	240K	16K	2K	2K
Additional Paid In Capital	901M	919M	922M	923M	927M
Retained Earnings	-843M	-881M	-916M	-920M	-925M
Total Common Equity	58.06M	38.56M	6.31M	2.06M	2.15M
Total Equity	58.06M	38.56M	6.31M	2.06M	2.15M
Total Liabilities And Equity	94.86M	64.94M	8.26M	2.76M	2.97M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.43M	1.6M	1.6M	1.6M	2.38M
ECS Total Common Shares Outstanding	1.43M	1.6M	1.6M	1.6M	2.35M
Book Value / Share	40.52	24.15	3.94	1.29	0.92
Tangible Book Value	58.06M	38.56M	6.31M	2.06M	2.15M
Tangible Book Value Per Share	40.52	24.15	3.94	1.29	0.92
Total Debt	29.36M	19.51M	0	0	0
Net Debt	-46.69M	-19.55M	-6.06M	-1.09M	-1.38M
Debt Equivalent Oper. Leases	11.15M	6.05M	3.42M	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	7.64M	7.42M	15K	15K	98K
Full Time Employees	41	34	1	1	1
Part Time Employees	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-78.75M	-37.73M	-35.14M	-4.68M	-4.18M
Depreciation & Amortization - CF	2.6M	2.76M	2.32M	2K	7K
Depreciation & Amortization, Total	2.6M	2.76M	2.32M	2K	7K
Amortization of Deferred Charges, Total - (CF)	383K	981K	1.34M	-	-
(Gain) Loss From Sale Of Asset	-	7K	7K	-	-
Asset Writedown & Restructuring Costs	740K	-	4.8M	-	-
Stock-Based Compensation (CF)	10.77M	3.53M	2.8M	435K	414K
Other Operating Activities, Total	-	2.28M	-12K	-	413K
Change In Accounts Receivable	3.56M	1.11M	3K	-4K	2K
Change In Accounts Payable	274K	-25K	-773K	-100K	97K
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	-1.04M	-2.14M	-5.48M	-625K	374K
Cash from Operations	-61.47M	-29.23M	-30.14M	-4.97M	-2.87M
Capital Expenditure	-3.32M	-216K	-197K	-	-98K
Sale of Property, Plant, and Equipment	-	23K	1.54M	-	-
Cash from Investing	-3.32M	-193K	1.35M	-	-98K
Long-Term Debt Issued, Total	25M	-	-	-	-
Total Debt Issued	25M	-	-	-	-
Long-Term Debt Repaid, Total	-	-8.33M	-18.1M	-	-
Total Debt Repaid	-	-8.33M	-18.1M	-	-
Issuance of Common Stock	1.04M	14.74M	92K	-	1.91M
Repurchase of Common Stock	-	-45K	-	-	-
Issuance of Preferred Stock	-	-	-	-	1.35M
Other Financing Activities, Total	-260K	-	-125K	-	-
Cash from Financing	25.78M	6.37M	-18.14M	-	3.26M
Net Change in Cash	-39.02M	-23.06M	-46.93M	-4.97M	294K
Supplemental Items
Cash Interest Paid	630K	2.17M	2.06M	-	-
Levered Free Cash Flow	-34.94M	-27.95M	-5.1M	-3.3M	-754K
Unlevered Free Cash Flow	-35.32M	-26.96M	-5.24M	-3.3M	-754K
Change In Net Working Capital	-2.64M	12.56M	-7.66M	729K	-1.18M
Net Debt Issued / Repaid	25M	-8.33M	-18.1M	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-39.8	-25.61	-48.66	-54.59	-92.31
Return on Total Capital	-44.4	-28.13	-55.33	-71.86	-125.27
Return On Equity %	-86.52	-78.11	-156.66	-111.8	-198.1
Return on Common Equity	-86.52	-78.11	-156.66	-111.8	-203.13
Margin Analysis
Gross Profit Margin %	-12.37K	-670.64	-325K	-3.52K	-27.16K
SG&A Margin	6.93K	449.76	244K	44.6K	57.34K
EBITDA Margin %	-18.65K	-1.03K	-524K	-48.1K	-84.36K
EBITA Margin %	-19.3K	-1.12K	-570K	-48.12K	-84.5K
EBIT Margin %	-19.3K	-1.12K	-570K	-48.12K	-84.5K
Income From Continuing Operations Margin %	-19.79K	-1.29K	-703K	-46.79K	-83.52K
Net Income Margin %	-19.79K	-1.29K	-703K	-46.79K	-83.52K
Net Avail. For Common Margin %	-19.79K	-1.29K	-703K	-46.79K	-85.64K
Normalized Net Income Margin	-12.25K	-756.4	-367K	-29.24K	-52.2K
Levered Free Cash Flow Margin	-8.78K	-956.38	-102K	-33K	-15.07K
Unlevered Free Cash Flow Margin	-8.87K	-922.49	-105K	-33K	-15.07K
Asset Turnover
Asset Turnover	0	0.04	0	0	0
Fixed Assets Turnover	0.03	0.23	0	10	0.11
Receivables Turnover (Average Receivables)	-	5.24	2	3.33	1.25
Short Term Liquidity
Current Ratio	4.91	2.23	4.22	3.98	2.45
Quick Ratio	4.81	1.62	3.1	1.58	1.71
Operating Cash Flow to Current Liabilities	-3.83	-1.21	-15.41	-7.18	-3.53
Days Sales Outstanding (Average Receivables)	-	69.64	182.5	109.8	292
Average Days Payable Outstanding	8.56	22.34	22.48	572.25	151.17
Long Term Solvency
Total Debt/Equity	50.58	50.61	-	-	-
Total Debt / Total Capital	33.59	33.6	-	-	-
LT Debt/Equity	35.77	5.68	-	-	-
Long-Term Debt / Total Capital	23.76	3.77	-	-	-
Total Liabilities / Total Assets	38.8	40.63	23.67	25.12	27.41
EBIT / Interest Expense	-	-10.38	-14.83	-	-
EBITDA / Interest Expense	-	-9.27	-13.63	-	-
(EBITDA - Capex) / Interest Expense	-	-9.33	-13.73	-	-
Total Debt / EBITDA	-0.4	-0.67	-	-	-
Net Debt / EBITDA	0.64	0.67	0.23	0.23	0.33
Total Debt / (EBITDA - Capex)	-0.39	-0.66	-	-	-
Net Debt / (EBITDA - Capex)	0.61	0.66	0.23	0.23	0.32
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	634.17	-99.83	100	-50
Gross Profit, 1 Yr. Growth %	-6.55	-58.2	-16.95	-97.84	285.8
EBITDA, 1 Yr. Growth %	-6.34	-57.51	-12.68	-81.63	-12.31
EBITA, 1 Yr. Growth %	-4.42	-55.25	-12.97	-83.11	-12.2
EBIT, 1 Yr. Growth %	-4.42	-55.25	-12.97	-83.11	-12.2
Earnings From Cont. Operations, 1 Yr. Growth %	-1.53	-52.09	-6.86	-86.68	-10.75
Net Income, 1 Yr. Growth %	-1.53	-52.09	-6.86	-86.68	-10.75
Normalized Net Income, 1 Yr. Growth %	-2.46	-52.44	-16.96	-84.07	-10.75
Diluted EPS Before Extra, 1 Yr. Growth %	-3.72	-52.69	-15.71	-86.7	-24.79
Accounts Receivable, 1 Yr. Growth %	-	-99.64	-75	400	-40
Net Property, Plant and Equip., 1 Yr. Growth %	3.23	-31.02	-99.98	-100	-
Total Assets, 1 Yr. Growth %	-35.18	-31.55	-87.28	-66.66	7.66
Tangible Book Value, 1 Yr. Growth %	-53.17	-33.59	-83.64	-67.29	4.36
Common Equity, 1 Yr. Growth %	-53.17	-33.59	-83.64	-67.29	4.36
Cash From Operations, 1 Yr. Growth %	7.81	-52.44	3.11	-83.51	-42.29
Capital Expenditures, 1 Yr. Growth %	-66.02	-93.5	-8.8	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-3	-16.32	-81.76	-35.26	-77.16
Unlevered Free Cash Flow, 1 Yr. Growth %	-1.94	-18.4	-80.58	-36.97	-77.16
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-88.79	-94.15	0
Gross Profit, 2 Yr. CAGR %	13.35	-39.02	-41.08	-86.6	-71.11
EBITDA, 2 Yr. CAGR %	13.88	-38.49	-39.09	-59.94	-59.86
EBITA, 2 Yr. CAGR %	15.22	-36.17	-37.59	-61.66	-61.49
EBIT, 2 Yr. CAGR %	15.22	-36.17	-37.59	-61.66	-61.49
Earnings From Cont. Operations, 2 Yr. CAGR %	-18.24	-31.31	-33.2	-64.78	-65.53
Net Income, 2 Yr. CAGR %	-18.24	-31.31	-33.2	-64.78	-65.53
Normalized Net Income, 2 Yr. CAGR %	16.94	-33.5	-37.16	-63.63	-62.29
Diluted EPS Before Extra, 2 Yr. CAGR %	-27.63	-32.51	-36.81	-66.54	-68.37
Accounts Receivable, 2 Yr. CAGR %	-	-	-97	11.8	73.21
Net Property, Plant and Equip., 2 Yr. CAGR %	113.12	-15.62	-98.86	-	574.54
Total Assets, 2 Yr. CAGR %	-6.76	-33.39	-70.49	-79.4	-40.09
Tangible Book Value, 2 Yr. CAGR %	-21.83	-44.24	-67.04	-76.87	-41.57
Common Equity, 2 Yr. CAGR %	-21.83	-44.24	-67.04	-76.87	-41.57
Cash From Operations, 2 Yr. CAGR %	22.66	-28.4	-29.97	-58.76	-69.15
Capital Expenditures, 2 Yr. CAGR %	242.06	-85.14	-75.65	-	-29.47
Levered Free Cash Flow, 2 Yr. CAGR %	9.01	-11.92	-60.93	-65.64	-61.55
Unlevered Free Cash Flow, 2 Yr. CAGR %	9.6	-13.49	-60.19	-65.01	-62.06
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	39.69	-	-	-70.71	-88.04
Gross Profit, 3 Yr. CAGR %	13.16	-20.04	-32.41	-80.42	-58.93
EBITDA, 3 Yr. CAGR %	11.64	-19.39	-30.87	-59.15	-47.99
EBITA, 3 Yr. CAGR %	12.53	-17.29	-29.22	-59.63	-49.47
EBIT, 3 Yr. CAGR %	12.53	-17.29	-29.22	-59.63	-49.47
Earnings From Cont. Operations, 3 Yr. CAGR %	14.03	-31.58	-23.98	-60.98	-51.99
Net Income, 3 Yr. CAGR %	14.03	-31.58	-23.98	-60.98	-51.99
Normalized Net Income, 3 Yr. CAGR %	13.56	-14.73	-28.39	-60.22	-50.94
Diluted EPS Before Extra, 3 Yr. CAGR %	-27.31	-37.19	-27.29	-62.43	-56.17
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-83.49	-9.14
Net Property, Plant and Equip., 3 Yr. CAGR %	141.03	46.33	-94.88	-	-79.52
Total Assets, 3 Yr. CAGR %	-0.07	-15.89	-61.64	-69.26	-64.25
Tangible Book Value, 3 Yr. CAGR %	-12.13	-25.96	-62.95	-67.12	-61.78
Common Equity, 3 Yr. CAGR %	-12.13	-25.96	-62.95	-67.12	-61.78
Cash From Operations, 3 Yr. CAGR %	7.52	-10.56	-19.14	-56.76	-53.87
Capital Expenditures, 3 Yr. CAGR %	93.45	-8.72	-72.79	-	-23.16
Levered Free Cash Flow, 3 Yr. CAGR %	-4.52	-1.68	-47.89	-53.77	-70.01
Unlevered Free Cash Flow, 3 Yr. CAGR %	-4.17	-2.85	-47.42	-53.6	-69.65
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-43.42	-14.48	-49.08	-	-
Gross Profit, 5 Yr. CAGR %	-20.07	-12.72	-13.7	-60.86	-51.89
EBITDA, 5 Yr. CAGR %	-14.77	-10.81	-13.27	-39.06	-44.38
EBITA, 5 Yr. CAGR %	-14.21	-9.35	-11.97	-39.19	-44.52
EBIT, 5 Yr. CAGR %	-14.21	-9.35	-11.97	-39.19	-44.52
Earnings From Cont. Operations, 5 Yr. CAGR %	-13.78	-7.03	-7.93	-47.54	-44.59
Net Income, 5 Yr. CAGR %	-13.78	-7.03	-7.93	-47.54	-44.59
Normalized Net Income, 5 Yr. CAGR %	-13.94	-8.23	-11.23	-39.36	-44.59
Diluted EPS Before Extra, 5 Yr. CAGR %	-22.6	-20.14	-31.27	-51.16	-47.9
Accounts Receivable, 5 Yr. CAGR %	-	-26.77	-77.83	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	78.7	54.31	-71.68	-	-63.92
Total Assets, 5 Yr. CAGR %	-2.26	-9.27	-38.65	-52.09	-54.15
Tangible Book Value, 5 Yr. CAGR %	-5.56	-16.82	-40.64	-53.51	-55.54
Common Equity, 5 Yr. CAGR %	-5.56	-16.82	-40.64	-53.51	-55.54
Cash From Operations, 5 Yr. CAGR %	1.06	-11.77	-9.43	-34.38	-45
Capital Expenditures, 5 Yr. CAGR %	43.24	-21.77	-15.56	-	-60.17
Levered Free Cash Flow, 5 Yr. CAGR %	-20.42	11.38	-33.82	-35.43	-53.86
Unlevered Free Cash Flow, 5 Yr. CAGR %	-20.25	10.58	-33.46	-35.43	-53.86